Evidence map›Paper›PMID 37720217›Full record

ArticleFrontiers in immunology2023

Interleukin-36γ is causative for liver damage upon infection with Rift Valley fever virus in type I interferon receptor-deficient mice.

Martina Anzaghe, Marc A Niles, Eugenia Korotkova, Monica Dominguez, Stefanie Kronhart, Samira Ortega Iannazzo, Ingo Bechmann, Malte Bachmann, Heiko Mühl, Georg Kochs and 1 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Martina AnzagheDivision of Immunology, Paul-Ehrlich-Institut, Langen, Germany.
Marc A NilesDivision of Immunology, Paul-Ehrlich-Institut, Langen, Germany.
Eugenia KorotkovaDivision of Immunology, Paul-Ehrlich-Institut, Langen, Germany.
Monica DominguezDivision of Immunology, Paul-Ehrlich-Institut, Langen, Germany.
Stefanie KronhartDivision of Immunology, Paul-Ehrlich-Institut, Langen, Germany.
Samira Ortega IannazzoDivision of Immunology, Paul-Ehrlich-Institut, Langen, Germany.
Ingo BechmannMedical Faculty, Institute for Anatomy, University Leipzig, Leipzig, Germany.
Malte BachmannPharmazentrum Frankfurt/ZAFES, University Hospital Frankfurt, Goethe-University Frankfurt am Main, Frankfurt am Main, Germany.
Heiko MühlPharmazentrum Frankfurt/ZAFES, University Hospital Frankfurt, Goethe-University Frankfurt am Main, Frankfurt am Main, Germany.
Georg KochsInstitute of Virology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Zoe WaiblerDivision of Immunology, Paul-Ehrlich-Institut, Langen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type I interferons (IFN) are pro-inflammatory cytokines which can also exert anti-inflammatory effects via the regulation of interleukin (IL)-1 family members. Several studies showed that interferon receptor (IFNAR)-deficient mice develop severe liver damage upon treatment with artificial agonists such as acetaminophen or polyinosinic:polycytidylic acid. In order to investigate if these mechanisms also play a role in an acute viral infection, experiments with the

Indexed as

Interleukin-1Receptor, Interferon alpha-betaRift Valley FeverAnimalsLiverMiceRift Valley fever virusIL1F9 protein, mouseInterleukin-1Receptor, Interferon alpha-betaanti-inflammatorydysregulationimmune pathologyinterleukin-36γliver injuryrift valley fever virustype I interferon

Identifiers

PMID37720217
PMCPMC10502725

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.